Strategy | Finance Blog
Healthcare Private Placement and M&A Transactions Review Week Ending March 2, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Eikon Therapeutics: The company raised $350.7 million of Series D venture funding from Foresite Capital, Lux Capital and The Column Group on February 26, 2025, putting the company's...
Technology Private Placement and M&A Transactions Review Week Ending Feb 23, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Lambda: The company raised $480 million of Series D venture funding in a deal led by Andra Capital and SGW on February 19, 2025, putting the company's pre-money valuation at $2.0...
Consumer Private Placement and M&A Transactions Review Week Ending Feb 23, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions A-Game: The company raised $18.5 million of venture funding through a combination of convertible debt and equity from undisclosed investors on February 19, 2025. The company is a...
Healthcare Private Placement and M&A Transactions Review Week Ending Feb 23, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Abridge: The company raised $250 million of Series D venture funding in a deal led by IVP and Elad Gil on February 19, 2005, putting the company's pre-money valuation at $2.5...
Technology Private Placement and M&A Transactions Review Week Ending Feb 16, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Groq: The company is in the process of raising $1.5 billion of venture funding from undisclosed investors on February 11, 2025. The company is a developer of an artificial...
Healthcare Private Placement and M&A Transactions Review Week Ending Feb 16, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Abcuro: The company raised $200 million of Series C venture funding in a deal led by New Enterprise Associates on February 12, 2025, putting the company's pre-money valuation at $500...
Consumer Private Placement and M&A Transactions Review Week Ending Feb 16, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions 80 Acres Farms: The company received $115 million of development capital from Barclays Climate Ventures, The Western and Southern Life Insurance Company, Virgo Investment Group,...
Technology Private Placement and M&A Transactions Review Week Ending Feb 9, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions StackAdapt: The company received $235 million of development capital from Teachers' Venture Growth, Intrepid Growth Partners, Round13 Capital and other investors on February 4, 2025....
Consumer Private Placement and M&A Transactions Review Week Ending Feb 9, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Vestaron: The company raised $82.9 million of funding in the from of equity and debt from undisclosed investors on February 6, 2025. The company is a developer of peptide-based...
Healthcare Private Placement and M&A Transactions Review Week Ending Feb 9, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Carlsmed: The company raised $64.5 million of Series C venture funding in a deal led by U.S. Venture Partners and B Capital Group on February 6, 2025. The Vertical Group also...